Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novavax (DE:NVV1)
FRANKFURT:NVV1
Novavax (NVV1) Stock Price & Analysis
2 Followers
NVV1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.33 - €10.19
Previous Close€4.42
Volume894.00
Average Volume (3M)7.17K
Market Cap
€619.44M
Enterprise Value€221.35M
Total Cash (Recent Filing)$651.10M
Total Debt (Recent Filing)$222.11M
Price to Earnings (P/E)N/A
Beta2.07
Next Earnings
May 07, 2024EPS Estimate
-€0.88Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding139,953,143
10 Day Avg. Volume2,182
30 Day Avg. Volume7,173
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-0.79
Price to Sales (P/S)0.31
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit0.11
Enterprise Value/Ebitda-0.45
Forecast
1Y Price Target
€9.05Price Target Upside104.60% Upside
Rating ConsensusHold
Number of Analyst Covering4
Novavax News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
14.18% Other Institutional Investors
85.82% Public Companies and
Individual Investors
NVV1 FAQ
What was Novavax’s price range in the past 12 months?
Novavax lowest stock price was €3.33 and its highest was €10.19 in the past 12 months.
What is Novavax’s market cap?
Currently, no data Available
When is Novavax’s upcoming earnings report date?
Novavax’s upcoming earnings report date is May 07, 2024 which is in 11 days.
How were Novavax’s earnings last quarter?
Novavax released its earnings results on Feb 28, 2024. The company reported -€1.336 earnings per share for the quarter, missing the consensus estimate of -€0.416 by -€0.921.
Is Novavax overvalued?
According to Wall Street analysts Novavax’s price is currently Undervalued.
Does Novavax pay dividends?
Novavax does not currently pay dividends.
What is Novavax’s EPS estimate?
Novavax’s EPS estimate is -€0.88.
How many shares outstanding does Novavax have?
Currently, no data Available
What happened to Novavax’s price movement after its last earnings report?
Novavax reported an EPS of -€1.336 in its last earnings report, missing expectations of -€0.416. Following the earnings report the stock price went down -25.853%.
Which hedge fund is a major shareholder of Novavax?
Among the largest hedge funds holding Novavax’s share is Coatue Management, LLC. It holds Novavax’s shares valued at 7M.
---
Novavax Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€9.05 (104.60% Upside)
€9.05 (104.60% Upside)
Blogger Sentiment
Bullish
DE:NVV1 Sentiment 79%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.40%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-17.86%
Trailing 12-Months
Company Description
Novavax
Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
---
NVV1 Earnings Call
Q4 2024
0:00 / 0:00
---
NVV1 Stock 12 Months Forecast
Average Price Target
€9.05
▲(104.60% Upside)
Technical Analysis
Best Analysts Covering NVV1
1 Year
1 Year Success Rate
17/35 ratings generated profit
1 Year Average Return
+151.07%
reiterated a buy rating 2 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 48.57% of your transactions generating a profit, with an average return of +151.07% per trade.
---